Schneider, M.; Köpke, M.B.; zehni, A.Z.; Vilsmaier, T.; Kessler, M.; Kailuweit, M.; Vattai, A.; Heidegger, H.H.; Cavaillès, V.; Jeschke, U.;
et al. Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways. Cancers 2023, 15, 3610.
https://doi.org/10.3390/cancers15143610
AMA Style
Schneider M, Köpke MB, zehni AZ, Vilsmaier T, Kessler M, Kailuweit M, Vattai A, Heidegger HH, Cavaillès V, Jeschke U,
et al. Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways. Cancers. 2023; 15(14):3610.
https://doi.org/10.3390/cancers15143610
Chicago/Turabian Style
Schneider, Mariella, Melitta B. Köpke, Alaleh Zati zehni, Theresa Vilsmaier, Mirjana Kessler, Magdalena Kailuweit, Aurelia Vattai, Helene Hildegard Heidegger, Vincent Cavaillès, Udo Jeschke,
and et al. 2023. "Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways" Cancers 15, no. 14: 3610.
https://doi.org/10.3390/cancers15143610
APA Style
Schneider, M., Köpke, M. B., zehni, A. Z., Vilsmaier, T., Kessler, M., Kailuweit, M., Vattai, A., Heidegger, H. H., Cavaillès, V., Jeschke, U., & Ditsch, N.
(2023). Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways. Cancers, 15(14), 3610.
https://doi.org/10.3390/cancers15143610
